论文信息 - Reply to R. Pham et al. - 字舞流文

Reply to R. Pham et al.

G. Meijer | C. Punt | R. Fijneman | Iris van 't Erve

[1] F. Gaiani,et al. Defects in MMR Genes as a Seminal Example of Personalized Medicine: From Diagnosis to Therapy , 2021, Journal of personalized medicine.

[2] P. Siersema,et al. The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care , 2021, Scientific Reports.

[3] Ritika Kundra,et al. Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer. , 2018, Cancer cell.

[4] S. Fox,et al. KRAS mutation testing of metastatic colorectal cancer in Australia: Where are we at? , 2014, Asia-Pacific journal of clinical oncology.

[5] Reiko Nishihara,et al. Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review , 2014, Molecular Cancer.